Addiction Science & Clinical Practice is affiliated with the International Network on Brief Interventions for Alcohol & Other Drugs.
Citation: Addiction Science & Clinical Practice 2018 13(Suppl 1):121
Page 3 of 12
Citation: Addiction Science & Clinical Practice 2018 13(Suppl 1):121
Addiction treatment improves substance use and criminal recidivism outcomes among justice-involved individuals with substance use disorders, but is underutilized. Although information exists regarding barriers...
Citation: Addiction Science & Clinical Practice 2018 13:19
The emergency department (ED) has long been recognized as providing critical access to the health care system for many, yet only in the past few decades has the ED visit been recognized as an opportunity to id...
Citation: Addiction Science & Clinical Practice 2018 13:18
Increasing understanding of the pathways and processes of recovery from cannabis use disorder may help in designing effective and attractive interventions to promote recovery. We report insights from individua...
Citation: Addiction Science & Clinical Practice 2018 13:16
Little is known about tobacco smoking behaviors of healthcare professionals in the Middle East where stress conditions are high and tobacco smoking regulations are either absent or loose. The objective of this...
Citation: Addiction Science & Clinical Practice 2018 13:17
Opioid-related overdose deaths have risen sharply among young adults. Despite this increase, access to evidence-based medication for opioid agonist treatment (OAT) for youth remains low. Among older adults, ba...
Citation: Addiction Science & Clinical Practice 2018 13:15
For over a decade, the vast majority of new hepatitis C virus (HCV) infections have been among young people who inject drugs (PWID). Well-characterized gaps in chronic HCV diagnosis, evaluation, and treatment ...
Citation: Addiction Science & Clinical Practice 2018 13:10
Contemporary advances in addiction neuroscience have paralleled increasing interest in the ancient mental training practice of mindfulness meditation as a potential therapy for addiction. In the past decade, ...
Citation: Addiction Science & Clinical Practice 2018 13:14
Alcohol and drug use are leading causes of morbidity and mortality that frequently go unidentified in medical settings. As part of a multi-phase study to implement electronic health record-integrated substanc...
Citation: Addiction Science & Clinical Practice 2018 13:8
HIV-infected people who use drugs (PWUD) exhibit the highest rates of non-adherence to antiretroviral therapy (ART) among people living with HIV. This contributes to poor treatment outcomes, increased morbidit...
Citation: Addiction Science & Clinical Practice 2018 13:12
This study investigates the impact of methamphetamine use on trauma patient outcomes.
Citation: Addiction Science & Clinical Practice 2018 13:11
Aboriginal and Torres Strait Islander Community Controlled Health Services (ACCHSs) around Australia have been asked to standardise screening for unhealthy drinking. Accordingly, screening with the 3-item AUD...
Citation: Addiction Science & Clinical Practice 2018 13:5
Research has identified drinking motives as the final common pathway to alcohol use, and associations between specific drinking motives and drinking patterns have consistently been demonstrated. Data on drinki...
Citation: Addiction Science & Clinical Practice 2018 13:7
Citation: Addiction Science & Clinical Practice 2018 13:13
While brief intervention (BI) for risky alcohol use generally yields positive effects among those identified by screening, effect sizes are small and there is unexplained heterogeneity in outcome. The heterog...
Citation: Addiction Science & Clinical Practice 2018 13:6
Upon publication of the original article
Citation: Addiction Science & Clinical Practice 2018 13:9
A growing body of evidence supports the effectiveness of injectable diacetylmorphine (i.e., heroin) for individuals with treatment-refractory opioid use disorder. Despite this evidence, and the increasing toll...
Citation: Addiction Science & Clinical Practice 2018 13:3
Increasing alcohol use is associated with increased risk of mortality among patients living with HIV (PLWH). This association varies by race/ethnicity among general outpatients, but racial/ethnic variation ha...
Citation: Addiction Science & Clinical Practice 2018 13:2
Methamphetamine (MA) is a highly addictive psychostimulant used by approximately 52 million people worldwide. Chronic MA abuse leads to detrimental physiological and neurological changes, as well as increases ...
Citation: Addiction Science & Clinical Practice 2018 13:4
Few studies describe medical complaints and substance use patterns related to attending music concerts. As such, the objective of this study is to describe patient demographics, substance use and intoxication ...
Citation: Addiction Science & Clinical Practice 2018 13:1
Over 1.6 million adolescents in the United States meet criteria for substance use disorders (SUDs). While there are promising treatments for SUDs, adolescents respond to these treatments differentially in part...
Citation: Addiction Science & Clinical Practice 2017 12:35
Substance use is common among people living with HIV (PLHIV) and is associated with worse outcomes along the HIV care continuum. One potentially effective clinic-based approach to addressing unhealthy substanc...
Citation: Addiction Science & Clinical Practice 2017 12:34
Screening and brief intervention (SBI) for unhealthy drinking has not been widely implemented in primary care partly due to reliance on physicians to perform it.
Citation: Addiction Science & Clinical Practice 2017 12:33
People who use drugs are an important priority for HIV programs. However, data related to their utilization of HIV services are limited. This paper reports patterns of HIV testing, drug use, and risk and servi...
Citation: Addiction Science & Clinical Practice 2017 12:27
Engaging people who drink alcohol or inject drugs in HIV care can be challenging, particularly in Eastern Europe. Healthcare facilities in Russia are organized by specialty; therefore linking patients from add...
Citation: Addiction Science & Clinical Practice 2017 12:30
Opioid addiction and overdose are epidemic in the U.S. Victims of traumatic injury are at greater than average risk for opioid misuse and related complications. Potential risk screens and preventive intervent...
Citation: Addiction Science & Clinical Practice 2017 12:28
Improving the extent to which evidence-based practices (EBPs)—treatments that have been empirically shown to be efficacious or effective—are integrated within routine practice is a well-documented challenge ac...
Citation: Addiction Science & Clinical Practice 2017 12:32
In 2010, the first comprehensive National HIV/AIDS Strategy for the United States was released and included three goals: (1) reducing the number of people who become infected with HIV, (2) increasing access to...
Citation: Addiction Science & Clinical Practice 2017 12:31
Citation: Addiction Science & Clinical Practice 2017 12:29
A greater understanding of the factors that influence long-term sustainment of quality improvement (QI) initiatives is needed to promote organizational ability to sustain QI practices over time, help improve f...
Citation: Addiction Science & Clinical Practice 2017 12:26
Though timely initiation of antiretroviral therapy (ART) is a vital component of effective HIV prevention, care and treatment, people who inject drugs are less likely to receive ART than their non-drug using c...
Citation: Addiction Science & Clinical Practice 2017 12:23
Contemporary studies about HIV care continuum (HCC) outcomes within substance using populations primarily focus on individual risk factors rather than provider- or systems-level influences. Over 25% of people...
Citation: Addiction Science & Clinical Practice 2017 12:24
Alcohol consumption has been associated with poor antiretroviral therapy (ART) adherence but less is known about its relationship to HIV viral suppression, or whether certain drinking patterns have a stronger ...
Citation: Addiction Science & Clinical Practice 2017 12:22
Although progress in science has driven advances in addiction medicine, this subject has not been adequately taught to medical trainees and physicians. As a result, there has been poor integration of evidence-...
Citation: Addiction Science & Clinical Practice 2017 12:21
Citation: Addiction Science & Clinical Practice 2017 12(Suppl 1):25
HIV prevalence remains high in Cambodia among female entertainment and sex workers (FESW), and amphetamine-type stimulant (ATS) use significantly increases risk of infection. A successful continuum of care (Co...
Citation: Addiction Science & Clinical Practice 2017 12:20
Persons living with HIV and unhealthy substance use are often less engaged in HIV care, have higher morbidity and mortality and are at increased risk of transmitting HIV to uninfected partners. We developed a ...
Citation: Addiction Science & Clinical Practice 2017 12:19
Substance use remains a leading cause of preventable death globally. A model of intervention known as screening, brief intervention, and referral to treatment (SBIRT) was developed decades ago to facilitate ti...
Citation: Addiction Science & Clinical Practice 2017 12:18
Criteria for alcohol use disorders (AUD) in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) were intended to result in a similar prevalence of AUD as DSM-IV. We evaluated the pre...
Citation: Addiction Science & Clinical Practice 2017 12:17
Interventions are needed to improve viral suppression rates among persons with HIV and substance use. A 3-arm randomized multi-site study (Metsch et al. in JAMA 316:156–70, 2016) was conducted to evaluate the ef...
Citation: Addiction Science & Clinical Practice 2017 12:16
People who smoke crack cocaine and people who inject drugs are at-risk for criminal justice involvement as well as HIV and HCV infection. Compared to criminal justice involvement, substance use treatment (SUT)...
Citation: Addiction Science & Clinical Practice 2017 12:13
Most patients with alcohol use disorders (AUDs) never receive alcohol treatment, and experts have recommended management of AUDs in primary care. The Choosing Healthier Drinking Options In primary CarE (CHOICE...
Citation: Addiction Science & Clinical Practice 2017 12:15
In 2016, the International Network on Brief Interventions for Alcohol & Other Drugs convened a meeting titled “Rethinking alcohol interventions in health care”. The aims of the meeting were to synthesize recen...
Citation: Addiction Science & Clinical Practice 2017 12:14
Women in South Africa who use alcohol and other drugs face multiple barriers to HIV care. These barriers make it difficult for women to progress through each step in the HIV treatment cascade from diagnosis to...
Citation: Addiction Science & Clinical Practice 2017 12:12
Persons living with HIV and substance use disorders face barriers to sustained engagement in medical care, leading to suboptimal antiretroviral treatment outcomes. Innovative mobile technology tools such as cu...
Citation: Addiction Science & Clinical Practice 2017 12:11
In the U.S. Department of Veterans Affairs (VA), residential treatment programs are an important part of the continuum of care for patients with a substance use disorder (SUD). However, a limited number of pro...
Citation: Addiction Science & Clinical Practice 2017 12:10
Opioid use disorder (OUD) affects approximately 21.9 million people worldwide. This study aims to determine the association between age of onset of opioid use and comorbid disorders, both physical and psychiat...
Citation: Addiction Science & Clinical Practice 2017 12:9
People living with HIV (PLWH) with a substance use disorder (SUD) tend to receive inadequate medical care in part because of a siloed healthcare system in which HIV and substance use services are delivered sep...
Citation: Addiction Science & Clinical Practice 2017 12:8
Buprenorphine maintenance for opioid dependence remains of limited availability among underserved populations, despite increases in US opioid misuse and overdose deaths. Low threshold primary care treatment mo...
Citation: Addiction Science & Clinical Practice 2017 12:7
Opioid dependence is a chronic condition with substantial health, economic and social costs. The study objective was to conduct a systematic review of published health-economic models of opioid agonist therapy...
Citation: Addiction Science & Clinical Practice 2017 12:6
Addiction Science & Clinical Practice is affiliated with the International Network on Brief Interventions for Alcohol & Other Drugs.
Speed
88 days to first decision for reviewed manuscripts only
71 days to first decision for all manuscripts
187 days from submission to acceptance
18 days from acceptance to publication
Citation Impact
3.088 - 2-year Impact Factor
1.249 - Source Normalized Impact per Paper (SNIP)
1.193 - SCImago Journal Rank (SJR)
Usage
237,813 Downloads
614 Altmetric mentions